Form 8-K - Current report:
SEC Accession No. 0001641172-25-005692
Filing Date
2025-04-22
Accepted
2025-04-22 16:15:56
Documents
44
Period of Report
2025-04-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40489
2 ex99-1.htm EX-99.1 22884
3 ex99-1_001.jpg GRAPHIC 523649
4 ex99-1_002.jpg GRAPHIC 1332057
5 ex99-1_003.jpg GRAPHIC 1011305
6 ex99-1_004.jpg GRAPHIC 973642
7 ex99-1_005.jpg GRAPHIC 308746
8 ex99-1_006.jpg GRAPHIC 612639
9 ex99-1_007.jpg GRAPHIC 423579
10 ex99-1_008.jpg GRAPHIC 977717
11 ex99-1_009.jpg GRAPHIC 791375
12 ex99-1_010.jpg GRAPHIC 301906
13 ex99-1_011.jpg GRAPHIC 953240
14 ex99-1_012.jpg GRAPHIC 852755
15 ex99-1_013.jpg GRAPHIC 792383
16 ex99-1_014.jpg GRAPHIC 611824
17 ex99-1_015.jpg GRAPHIC 334679
18 ex99-1_016.jpg GRAPHIC 1051712
19 ex99-1_017.jpg GRAPHIC 828834
20 ex99-1_018.jpg GRAPHIC 884198
21 ex99-1_019.jpg GRAPHIC 527524
22 ex99-1_020.jpg GRAPHIC 788858
23 ex99-1_021.jpg GRAPHIC 614399
24 ex99-1_022.jpg GRAPHIC 305268
25 ex99-1_023.jpg GRAPHIC 683328
26 ex99-1_024.jpg GRAPHIC 900207
27 ex99-1_025.jpg GRAPHIC 726212
28 ex99-1_026.jpg GRAPHIC 800737
29 ex99-1_027.jpg GRAPHIC 672015
30 ex99-1_028.jpg GRAPHIC 403721
31 ex99-1_029.jpg GRAPHIC 267014
32 ex99-1_030.jpg GRAPHIC 815188
  Complete submission text file 0001641172-25-005692.txt   29230689

Data Files

Seq Description Document Type Size
33 XBRL SCHEMA FILE maia-20250422.xsd EX-101.SCH 3024
34 XBRL LABEL FILE maia-20250422_lab.xml EX-101.LAB 34240
35 XBRL PRESENTATION FILE maia-20250422_pre.xml EX-101.PRE 24171
46 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3824
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41455 | Film No.: 25857917
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)